These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 529620

  • 1. [Studies on abnormalities of calcium, vitamin D and bone metabolism in patients on maintenance hemodialysis (author's transl)].
    Kitoh C.
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):503-18. PubMed ID: 529620
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
    Offermann G, Schaefer K, Schulz A, Delling G.
    Klin Wochenschr; 1976 Jul 01; 54(13):625-32. PubMed ID: 940299
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)].
    Sebert JL, Fournier AE, Gueris J, Marie P, Coevoet B, de Fremont JF, Lambrey G, Kuntz D.
    Nouv Presse Med; 1977 Nov 12; 6(38):3533-7. PubMed ID: 341079
    [No Abstract] [Full Text] [Related]

  • 6. [Study on calcium-regulating hormone in patients on chronic hemodialysis with special reference to renal osteodystrophy (ROD) (author's transl)].
    Kudo S.
    Nihon Jinzo Gakkai Shi; 1982 Feb 12; 24(2):181-96. PubMed ID: 7098141
    [No Abstract] [Full Text] [Related]

  • 7. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
    Pogglitsch H, Schmidberger H, Gell G.
    MMW Munch Med Wochenschr; 1976 Jan 30; 118(5):131-6. PubMed ID: 814443
    [Abstract] [Full Text] [Related]

  • 8. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW.
    Kidney Int Suppl; 1993 Feb 30; 40():S92-100. PubMed ID: 8445845
    [No Abstract] [Full Text] [Related]

  • 9. [Vitamin A status of patients with chronic renal failure in relation to renal osteodystrophy].
    Stein G, Abendroth K, Kokot F, Keil E, Schöne S, Wessel G, Fünfstück R, Sperschneider H.
    Z Urol Nephrol; 1985 Mar 30; 78(3):159-65. PubMed ID: 4002896
    [Abstract] [Full Text] [Related]

  • 10. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL, Marie A, Kuntz D, Marie P, Gueris J, Smadja A, Fournier A, Quichaud J.
    Rev Rhum Mal Osteoartic; 1981 Mar 30; 48(7-9):535-41. PubMed ID: 7291931
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
    Bordier PJ, Marie PJ, Arnaud CD.
    Kidney Int Suppl; 1975 Jan 30; (2):102-12. PubMed ID: 1057669
    [No Abstract] [Full Text] [Related]

  • 15. COSMOS Project: Hemodialysis scenario in Europe.
    Cannata-Andía JB, Fernández Martín JL.
    Nefrologia; 2016 Jan 30; 36(4):381-8. PubMed ID: 27117398
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Renal osteodystrophy. I. Recent pathophysiological acquisitions (author's transl)].
    Sebert JL, Fournier A, Gueris J, Marie P, Coevoet B, de Fremont JF, Lambrey G, Kuntz D.
    Nouv Presse Med; 1977 Nov 05; 6(37):3419-24. PubMed ID: 341075
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.